HK1215187A1 - 炎症性疾病的抑制劑 - Google Patents

炎症性疾病的抑制劑

Info

Publication number
HK1215187A1
HK1215187A1 HK16103241.3A HK16103241A HK1215187A1 HK 1215187 A1 HK1215187 A1 HK 1215187A1 HK 16103241 A HK16103241 A HK 16103241A HK 1215187 A1 HK1215187 A1 HK 1215187A1
Authority
HK
Hong Kong
Prior art keywords
inhibitor
inflammatory conditions
inflammatory
conditions
Prior art date
Application number
HK16103241.3A
Other languages
English (en)
Inventor
Emma Jane Blain
Victor Colin Duance
Ifor Delme Bowen
Ahmed Yasine Ali
Original Assignee
Compton Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0912526A external-priority patent/GB0912526D0/en
Priority claimed from GBGB0921086.5A external-priority patent/GB0921086D0/en
Application filed by Compton Dev Ltd filed Critical Compton Dev Ltd
Publication of HK1215187A1 publication Critical patent/HK1215187A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
HK16103241.3A 2009-07-18 2016-03-21 炎症性疾病的抑制劑 HK1215187A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0912526A GB0912526D0 (en) 2009-07-18 2009-07-18 Inhibitor of inflammatory conditions
GBGB0921086.5A GB0921086D0 (en) 2009-12-02 2009-12-02 Inhibitor of inflammatory conditions

Publications (1)

Publication Number Publication Date
HK1215187A1 true HK1215187A1 (zh) 2016-08-19

Family

ID=42813133

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16103241.3A HK1215187A1 (zh) 2009-07-18 2016-03-21 炎症性疾病的抑制劑
HK16103239.7A HK1215186A1 (zh) 2009-07-18 2016-03-21 炎症性疾病的抑制劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16103239.7A HK1215186A1 (zh) 2009-07-18 2016-03-21 炎症性疾病的抑制劑

Country Status (6)

Country Link
US (1) US9439936B2 (zh)
EP (4) EP3868391B1 (zh)
CN (2) CN104922183B (zh)
ES (3) ES2874862T3 (zh)
HK (2) HK1215187A1 (zh)
WO (1) WO2011010080A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3868391B1 (en) * 2009-07-18 2024-05-22 Compton Developments Limited Therapeutic uses of an organic solvent extract of boswellia frereana oleoresin
TWI565480B (zh) * 2014-03-14 2017-01-11 國立陽明大學 羽扇豆醇醋酸酯微脂體及其用於製備抑制蝕骨細胞生成藥物的應用
GB201520805D0 (en) * 2015-05-27 2016-01-06 Bel Viso Lab Llc Cosmeceutical
KR101786999B1 (ko) * 2016-10-04 2017-10-18 대구가톨릭대학교산학협력단 귀전우로부터 분리된 화합물을 포함하는 대사성 질환의 예방 또는 치료용 조성물
CN108451957A (zh) * 2018-05-23 2018-08-28 苏州大学附属第医院 3-乙酰基-11-酮基-β-乳香酸在制备治疗假体周围骨溶解药物中的用途
CN111000849A (zh) * 2019-12-19 2020-04-14 淮阴师范学院 羽扇豆醇dyc-6的应用和产品
CN111458490B (zh) * 2020-03-18 2023-06-27 广州市华永睿健生物科技有限公司 长寿家族的肠道代谢图谱的建立及其在增龄健康领域的应用
WO2023147641A1 (en) * 2022-02-07 2023-08-10 GERVÁSIO ALVES DA SILVA, Társis Anti-inflammatory, immunomodulatory and analgesic agents from tree exudates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
CN1304007C (zh) * 2002-02-04 2007-03-14 中国医学科学院药物研究所 乙酰乳香酸在制备肿瘤转移抑制剂中的应用
US7645461B2 (en) * 2003-03-18 2010-01-12 Key Neurotek AG Method of treating cerebral ischemia with hydrogenation products of frankincense extracts
CN101024029B (zh) * 2006-02-22 2010-08-18 易佑元 一种治疗骨性关节炎、风湿性关节炎的药物
EP3868391B1 (en) * 2009-07-18 2024-05-22 Compton Developments Limited Therapeutic uses of an organic solvent extract of boswellia frereana oleoresin

Also Published As

Publication number Publication date
EP3868391A1 (en) 2021-08-25
US9439936B2 (en) 2016-09-13
ES2874862T3 (es) 2021-11-05
CN102497872A (zh) 2012-06-13
WO2011010080A1 (en) 2011-01-27
EP2926823B1 (en) 2017-12-27
CN104922183A (zh) 2015-09-23
CN104922183B (zh) 2020-04-21
HK1215186A1 (zh) 2016-08-19
US20120177754A1 (en) 2012-07-12
ES2540064T3 (es) 2015-07-08
EP3868391B1 (en) 2024-05-22
ES2661441T3 (es) 2018-04-02
EP2926824A1 (en) 2015-10-07
EP2926823A1 (en) 2015-10-07
EP2456451B1 (en) 2015-04-15
EP2926824B1 (en) 2021-04-21
EP2456451A1 (en) 2012-05-30
CN102497872B (zh) 2015-04-29

Similar Documents

Publication Publication Date Title
ZA201700326B (en) Inhibitors of beta-secretase
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
HK1215186A1 (zh) 炎症性疾病的抑制劑
EP2440054A4 (en) PYRIDILTRIA INHIBITOR OF HEDGEHOG SIGNALING
IL218018A0 (en) Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
HK1156306A1 (zh) 作為 -脯氨酰基- -羥化酶抑制劑的取代的二氫吡唑啉酮類化合物
ZA201206456B (en) Uses of dgati inhibitors
EP2536468A4 (en) TREATMENT OF CHRONIC INFLAMMATORY DISEASES
EP2519508A4 (en) METALLO ENZYME INHIBITOR COMPOUNDS
HK1171624A1 (zh) 認知能力下降的抑制劑
HK1167323A1 (zh) 認知能力下降抑制劑
PL2506840T3 (pl) Zastosowania inhibitorów czynnika indukowalnego niedotlenieniem
GB0907886D0 (en) Corrosion inhibitor
GB201020798D0 (en) Corrosion inhibitors
EP2465524A4 (en) INHIBITOR OF SELF-ANTIBODY PRODUCTION
IL217756A0 (en) Inhibitors of jnk
EP2542232A4 (en) FATTY ACID INHIBITORS
EP2418208A4 (en) INHIBITOR OF INCREASE IN GIP RATE
PT2411376E (pt) Inibidores de nf-kb
GB0912526D0 (en) Inhibitor of inflammatory conditions
GB0921086D0 (en) Inhibitor of inflammatory conditions
IL215486A0 (en) Compositions of cholinesterase inhibitors
GB0912788D0 (en) Corrosion inhibitor
GB0908609D0 (en) New use of isoQC inhibitors
GB201010218D0 (en) Corrosion inhibitor